Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Grant or award Director acquired 34,403 shares (grant or award)
  2. 4 Grant or award Director acquired 34,403 shares (grant or award)
  3. 4 Grant or award Director acquired 34,403 shares (grant or award)
  4. 4 Grant or award Director acquired 34,403 shares (grant or award)
  5. 4 Grant or award Director acquired 34,403 shares (grant or award)
  6. 4 Grant or award Chairman acquired 34,403 shares (grant or award)
  7. 4 Grant or award Director acquired 34,403 shares (grant or award)
  8. 4 Grant or award Director acquired 34,403 shares (grant or award)
  9. 4 Shares withheld for taxes SVP, Bioservices gave up 561 shares (to pay taxes)
  10. 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 480 shares (to pay taxes)
  11. 4/A Grant or award SVP, Bioservices acquired 62,500 shares (grant or award)
  12. 4 Open-market sale Director sold 35,000 shares at $5.83 ($204,050)
  13. 4 Open-market sale Director sold 10,000 shares at $5.73 ($57,300)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award SVP, General Counsel, Corp Sec acquired 62,500 shares (grant or award)
  16. 4 Grant or award SVP, Products Business acquired 62,500 shares (grant or award)
  17. 4 Grant or award EVP, Chief Financial Officer acquired 146,888 shares (grant or award)
  18. 4 Grant or award SVP, R&D, CMO acquired 62,500 shares (grant or award)
  19. 4 Grant or award SVP, Bioservices acquired 62,500 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 282,500 shares (grant or award)

Page 4 of 49 · 970 filings